165 related articles for article (PubMed ID: 33906314)
1. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of locally advanced cervical cancer presenting with obstructive uropathy: An institutional audit.
Salunkhe R; Chopra S; Kulkarni S; Shetty N; Engineer R; Mahantshetty U; Ghosh J; Gupta S; Shrivastava SK
Indian J Cancer; 2020; 57(4):416-422. PubMed ID: 33078748
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of ureteral obstruction in primary cervical cancer.
Lee SK; Jones HW
Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
[TBL] [Abstract][Full Text] [Related]
4. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
5. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer.
Emmert C; Rassler J; Köhler U
Arch Gynecol Obstet; 1997; 259(3):147-51. PubMed ID: 9187468
[TBL] [Abstract][Full Text] [Related]
6. Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort.
Lapitan MC; Buckley BS
J Obstet Gynaecol Res; 2011 Aug; 37(8):1061-70. PubMed ID: 21481096
[TBL] [Abstract][Full Text] [Related]
7. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
8. Indications for percutaneous nephrostomy in patients with obstructive uropathy due to malignant urogenital neoplasias.
Romero FR; Broglio M; Pires SR; Roca RF; Guibu IA; Perez MD
Int Braz J Urol; 2005; 31(2):117-24. PubMed ID: 15877830
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous nephrostomy in gynecologic oncology patients.
Soper JT; Blaszczyk TM; Oke E; Clarke-Pearson D; Creasman WT
Am J Obstet Gynecol; 1988 May; 158(5):1126-31. PubMed ID: 2453117
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous nephrostomy in the management of advanced and terminal-stage gynecologic malignancies: outcome and complications.
Plesinac-Karapandzic V; Masulovic D; Markovic B; Djuric-Stefanovic A; Plesinac S; Vucicevic D; Milovanovic Z; Milosevic Z
Eur J Gynaecol Oncol; 2010; 31(6):645-50. PubMed ID: 21319508
[TBL] [Abstract][Full Text] [Related]
11. Outcome of palliative urinary diversion in the treatment of advanced malignancies.
Shekarriz B; Shekarriz H; Upadhyay J; Banerjee M; Becker H; Pontes JE; Wood DP
Cancer; 1999 Feb; 85(4):998-1003. PubMed ID: 10091780
[TBL] [Abstract][Full Text] [Related]
12. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
Gasparini M; Carroll P; Stoller M
Urology; 1991 Nov; 38(5):408-12. PubMed ID: 1719688
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer: Renal complications and survival after percutaneous nephrostomy.
Souza AC; Souza AN; Kirsztajn R; Kirsztajn GM
Rev Assoc Med Bras (1992); 2016; 62(3):255-61. PubMed ID: 27310550
[TBL] [Abstract][Full Text] [Related]
14. Palliation of obstructive nephropathy due to malignancy.
Harrington KJ; Pandha HS; Kelly SA; Lambert HE; Jackson JE; Waxman J
Br J Urol; 1995 Jul; 76(1):101-7. PubMed ID: 7544201
[TBL] [Abstract][Full Text] [Related]
15. Win or lose? Percutaneous nephrostomy for a terminal-stage cervical-cancer patient featuring obstructive uropathy.
Chang HL; Lim HW; Su FH; Tsai ST; Wang YW
J Palliat Care; 2006; 22(1):57-60. PubMed ID: 16689418
[No Abstract] [Full Text] [Related]
16. Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease.
Lau MW; Temperley DE; Mehta S; Johnson RJ; Barnard RJ; Clarke NW
Br J Urol; 1995 Nov; 76(5):565-9. PubMed ID: 8535673
[TBL] [Abstract][Full Text] [Related]
17. Operative retroperitoneal ureteral catheterization for obstructive uropathy in primary locally advanced carcinoma of the cervix: description of a technique and experience.
Rose PG
Gynecol Oncol; 1996 Apr; 61(1):79-82. PubMed ID: 8626122
[TBL] [Abstract][Full Text] [Related]
18. The role of percutaneous nephrostomy in malignant urinary tract obstruction.
Watkinson AF; A'Hern RP; Jones A; King DM; Moskovic EC
Clin Radiol; 1993 Jan; 47(1):32-5. PubMed ID: 8428414
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous nephrostomy: its value in obstructive uropathy complicating carcinoma of cervix uterus.
Chan S; Robinson AC; Johnson RJ
Clin Oncol (R Coll Radiol); 1990 May; 2(3):156-8. PubMed ID: 2261404
[TBL] [Abstract][Full Text] [Related]
20. Nephrostomy in patients with ureteral obstruction secondary to nonurologic malignancy. Obstructive uropathy in malignant disease.
McNamara TE; Butkus DE
Arch Intern Med; 1980 Apr; 140(4):494-7. PubMed ID: 7362379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]